| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.19 | 5e-09 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.14 | 6e-06 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |